Bio-Techne Expands Collaboration With Leica To Enhance Spatial Multiomics Research Capabilities

(RTTNews) - Bio-Techne Corp. (TECH), Wednesday announced expanded collaboration between its spatial biology brand, Advanced Cell Diagnostics (ACD), and Leica Biosystems, a provider of anatomic pathology solutions, to enhance its spatial multiomics research capabilities.

The partnership focuses on automation of ACD's new RNAscope Multiomic LS Assay and protease-free workflows on Leica's BOND RX research staining instrument.

The integration of these technologies aim to provide cutting-edge tools that enhance precision and scalability in life science research.

In the pre-market hours, Bio-Techne's stock is trading at $57.28, down 0.12 percent on the Nasdaq.